AZUXY

Azul S.A. filed its Q1 2026 MD&A, reporting total revenue of R$5,471.4 million (+1.4% YoY) and…

Azul's post-Chapter 11 balance sheet is significantly deleveraged with a much lower debt burden and a cash cushion. The underlying operating improvement (32% operating profit growth on 1.4% revenue…

Azul S.A. announced that its common shares and ADSs have been approved for listing on NYSE…

The uplisting to NYSE American and planned move to NYSE is a significant positive catalyst for Azul's ADS liquidity and investor access. Traders should monitor for potential increased institutional…

Azul reported strong 1Q26 results with record EBITDA of R$1,699.4 million (up 22.6% YoY) and…

Post-restructuring momentum is strong; watch for sustained margin expansion and continued deleveraging in coming quarters. Fuel price sensitivity remains a risk, but cost initiatives are cushioning…

Azul S.A. filed an F-1 registration statement to register the resale of up to 406,383,345 common…

The registration of nearly all outstanding shares for resale creates a severe overhang that will likely pressure AZUXY's OTC-traded ADSs. Monitor for the effective date of the registration statement…